REGENERON PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 8 2024 08:47:18 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 8 2024 08:50:04 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 8 2024 10:58:01 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 8 2024 08:45:08 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 8 2024 09:27:20 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 8 2024 08:50:04 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

09 8 2024 08:48:01 提供 NetDania Notify

Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast

07 8 2024 15:05:01 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

02 8 2024 08:46:30 提供 NetDania Notify

Regeneron Reports Second Quarter 2024 Financial and Operating Results

01 8 2024 05:30:00 提供 Nasdaq GlobeNewswire

Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation

31 7 2024 06:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

12 7 2024 08:45:06 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

11 7 2024 09:10:53 提供 NetDania Notify

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD

03 7 2024 00:00:00 提供 Nasdaq GlobeNewswire

Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

28 6 2024 06:00:00 提供 Nasdaq GlobeNewswire

Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

27 6 2024 15:05:00 提供 Nasdaq GlobeNewswire

Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine

26 6 2024 16:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

25 6 2024 08:45:03 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

24 6 2024 08:56:19 提供 NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 6 2024 09:29:52 提供 NetDania Notify